Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.45
(0.0%)
CNY 7.45
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 240.72 Million | 299.99 Million | 347.28 Million | 259.12 Million | 277.99 Million | 254.56 Million |
| Cost of Revenue | 120.3 Million | 123.08 Million | 153.61 Million | 137.76 Million | 148.7 Million | 112.41 Million |
| Gross Profit | 120.42 Million | 176.9 Million | 193.67 Million | 121.36 Million | 129.28 Million | 142.14 Million |
| Operating Expenses | 68.54 Million | 101.95 Million | 155.92 Million | 132.01 Million | 131.83 Million | 137.81 Million |
| Selling, General and Administrative Expenses | 49.55 Million | 77.85 Million | 90.32 Million | 74.26 Million | 78.43 Million | 91.04 Million |
| Research and Development Expenses | 22.55 Million | 29.94 Million | 28.64 Million | 29.52 Million | 29.64 Million | 27.28 Million |
| Other Expenses | -6.53 Million | -5.84 Million | 36.95 Million | 28.22 Million | 23.76 Million | -23.4 Million |
| Cost and Expenses | 185.55 Million | 225.04 Million | 309.53 Million | 269.77 Million | 280.54 Million | 250.23 Million |
| Operating Income | 55.17 Million | 152.56 Million | 57.24 Million | 12.46 Million | 29.58 Million | 22.17 Million |
| Interest Expense | 5.38 Million | 10.31 Million | 12.37 Million | 17.68 Million | 18.17 Million | 14.89 Million |
| Income Tax Expense | 6 Million | 20.52 Million | 11.47 Million | 8.81 Million | 33.23 Million | 12.47 Million |
| Earnings before Tax | 56.02 Million | 131.21 Million | 57.13 Million | -23.34 Million | 6.82 Million | -1.22 Million |
| Net Income | 62.87 Million | 121.6 Million | 53.85 Million | -32.15 Million | -26.4 Million | 21.29 Million |
| Earnings Per Share Basic | 0.10 | 0.19 | 0.08 | -0.05 | -0.04 | 0.03 |
| Earnings Per Share Diluted | 0.10 | 0.19 | 0.08 | -0.05 | -0.04 | 0.03 |
| Weighted Average Shares Outstanding | 628.7 Million | 644 Million | 644 Million | 644 Million | 644 Million | 709.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 628.7 Million | 644 Million | 644 Million | 644 Million | 644 Million | 709.94 Million |
| Gross Margin | 0.50 | 0.59 | 0.56 | 0.47 | 0.47 | 0.56 |
| EBIT Margin | 0.42 | 0.67 | 0.35 | 0.27 | 0.31 | 0.27 |
| Profit Margin | 0.26 | 0.41 | 0.16 | -0.12 | -0.10 | 0.08 |
| EBITDA | 101.11 Million | 183.28 Million | 120.47 Million | 59.72 Million | 93.14 Million | 70.87 Million |
| Earnings Before Tax Margin | 0.23 | 0.51 | 0.16 | 0.05 | 0.11 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 66 Million | 37.29 Million | 70.3 Million | 240.72 Million | 46.11 Million | 75.71 Million |
| Cost of Revenue | 32.63 Million | 16.63 Million | 39.55 Million | 117 Million | 21.36 Million | 43.71 Million |
| Gross Profit | 33.37 Million | 20.65 Million | 30.75 Million | 123.71 Million | 24.75 Million | 31.99 Million |
| Operating Expenses | 44.91 Million | 32.45 Million | 38.15 Million | 115.44 Million | 39.98 Million | 24.29 Million |
| Selling, General and Administrative Expenses | 39.48 Million | 16.97 Million | 32.52 Million | - | -13.53 Million | 29.35 Million |
| Research and Development Expenses | 5.43 Million | 5.89 Million | 5.49 Million | - | 6.49 Million | 5.92 Million |
| Other Expenses | - | 34.73 Million | -12.8 Thousand | 851.85 Thousand | -429.12 Thousand | 289.74 Thousand |
| Cost and Expenses | 77.54 Million | 49.09 Million | 77.71 Million | 232.45 Million | 61.35 Million | 68.01 Million |
| Operating Income | -11.54 Million | -12.72 Million | -5.51 Million | 55.17 Million | -21.37 Million | -6.99 Million |
| Interest Expense | 1.21 Million | 1.26 Million | 1.34 Million | 5.38 Million | 2.02 Million | -2.93 Million |
| Income Tax Expense | -14.23 Million | 7.27 Million | -1.16 Million | 6 Million | -6.75 Million | 1.84 Million |
| Earnings before Tax | -17.18 Million | 22 Million | -5.52 Million | 56.02 Million | -21.8 Million | -6.7 Million |
| Net Income | 5.04 Million | 18.84 Million | -3.71 Million | 62.87 Million | -11.82 Million | -7.03 Million |
| Earnings Per Share Basic | 0.01 | 0.03 | -0.01 | - | -0.02 | -0.01 |
| Earnings Per Share Diluted | 0.01 | 0.03 | -0.01 | - | -0.02 | -0.01 |
| Weighted Average Shares Outstanding | 644 Million | 644 Million | 647.34 Million | 628.7 Million | 647.34 Million | 657.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 644 Million | 644 Million | 647.34 Million | 628.7 Million | 647.34 Million | 657.9 Million |
| Gross Margin | 0.51 | 0.55 | 0.44 | 0.51 | 0.54 | 0.42 |
| EBIT Margin | -0.24 | 0.71 | -0.09 | - | 0.02 | -0.07 |
| Profit Margin | 0.08 | 0.51 | -0.05 | 0.26 | -0.26 | -0.09 |
| EBITDA | -15.96 Million | 26.49 Million | -6.33 Million | - | 802.63 Thousand | -5.65 Million |
| Earnings Before Tax Margin | -0.17 | -0.34 | -0.08 | 0.23 | -0.46 | -0.09 |
6240
ASUR
301151
KREBSBIO
VRSRF
GREAVESCOT